Klebl BM - Search Results

1

Klebl BM, Müller G. Klebl BM, et al. Expert Opin Ther Targets. 2005 Oct;9(5):975-93. doi: 10.1517/14728222.9.5.975. Expert Opin Ther Targets. 2005. PMID: 16185153 Review.

2

Evaluation of kinase inhibitor selectivity by chemical proteomics.

Daub H, Godl K, Brehmer D, Klebl B, Müller G. Daub H, et al. Assay Drug Dev Technol. 2004 Apr;2(2):215-24. doi: 10.1089/154065804323056558. Assay Drug Dev Technol. 2004. PMID: 15165517 Review.

3

Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition.

Backes A, Zech B, Felber B, Klebl B, Müller G. Backes A, et al. Expert Opin Drug Discov. 2008 Dec;3(12):1427-49. doi: 10.1517/17460440802580106. Expert Opin Drug Discov. 2008. PMID: 23506107

4

Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition.

Backes A, Zech B, Felber B, Klebl B, Müller G. Backes A, et al. Expert Opin Drug Discov. 2008 Dec;3(12):1409-25. doi: 10.1517/17460440802579975. Expert Opin Drug Discov. 2008. PMID: 23506106

5

Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.

Kéri G, Székelyhidi Z, Bánhegyi P, Varga Z, Hegymegi-Barakonyi B, Szántai-Kis C, Hafenbradl D, Klebl B, Muller G, Ullrich A, Erös D, Horváth Z, Greff Z, Marosfalvi J, Pató J, Szabadkai I, Szilágyi I, Szegedi Z, Varga I, Wáczek F, Orfi L. Kéri G, et al. Assay Drug Dev Technol. 2005 Oct;3(5):543-51. doi: 10.1089/adt.2005.3.543. Assay Drug Dev Technol. 2005. PMID: 16305311 Review.

6

Advances in anti-viral therapeutics.

Klebl BM. Klebl BM. Expert Opin Investig Drugs. 2005 Mar;14(3):343-8. doi: 10.1517/13543784.14.3.343. Expert Opin Investig Drugs. 2005. PMID: 15833066

7

Cellular targets of gefitinib.

Brehmer D, Greff Z, Godl K, Blencke S, Kurtenbach A, Weber M, Müller S, Klebl B, Cotten M, Kéri G, Wissing J, Daub H. Brehmer D, et al. Cancer Res. 2005 Jan 15;65(2):379-82. Cancer Res. 2005. PMID: 15695376

8

Host cell targets in HCV therapy: novel strategy or proven practice?

Klebl BM, Kurtenbach A, Salassidis K, Daub H, Herget T. Klebl BM, et al. Antivir Chem Chemother. 2005;16(2):69-90. doi: 10.1177/095632020501600201. Antivir Chem Chemother. 2005. PMID: 15889531 Free article. Review.

9

Screening assay for the identification of deoxyhypusine synthase inhibitors.

Sommer MN, Bevec D, Klebl B, Flicke B, Hölscher K, Freudenreich T, Hauber I, Hauber J, Mett H. Sommer MN, et al. J Biomol Screen. 2004 Aug;9(5):434-8. doi: 10.1177/1087057104264031. J Biomol Screen. 2004. PMID: 15296643

10

Chemical kinomics - a target gene family approach in chemical biology.

Klebl BM. Klebl BM. Drug Discov Today Technol. 2004 Sep;1(1):25-34. doi: 10.1016/j.ddtec.2004.08.013. Drug Discov Today Technol. 2004. PMID: 24981264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page